全文获取类型
收费全文 | 17039篇 |
免费 | 1000篇 |
国内免费 | 136篇 |
专业分类
耳鼻咽喉 | 139篇 |
儿科学 | 398篇 |
妇产科学 | 355篇 |
基础医学 | 1850篇 |
口腔科学 | 460篇 |
临床医学 | 1856篇 |
内科学 | 3954篇 |
皮肤病学 | 206篇 |
神经病学 | 1787篇 |
特种医学 | 492篇 |
外科学 | 2365篇 |
综合类 | 74篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 1305篇 |
眼科学 | 353篇 |
药学 | 944篇 |
中国医学 | 22篇 |
肿瘤学 | 1602篇 |
出版年
2024年 | 14篇 |
2023年 | 142篇 |
2022年 | 283篇 |
2021年 | 544篇 |
2020年 | 303篇 |
2019年 | 506篇 |
2018年 | 548篇 |
2017年 | 440篇 |
2016年 | 425篇 |
2015年 | 502篇 |
2014年 | 741篇 |
2013年 | 915篇 |
2012年 | 1315篇 |
2011年 | 1430篇 |
2010年 | 730篇 |
2009年 | 666篇 |
2008年 | 1216篇 |
2007年 | 1193篇 |
2006年 | 1065篇 |
2005年 | 1061篇 |
2004年 | 1002篇 |
2003年 | 887篇 |
2002年 | 802篇 |
2001年 | 106篇 |
2000年 | 80篇 |
1999年 | 113篇 |
1998年 | 144篇 |
1997年 | 114篇 |
1996年 | 105篇 |
1995年 | 106篇 |
1994年 | 77篇 |
1993年 | 68篇 |
1992年 | 47篇 |
1991年 | 43篇 |
1990年 | 46篇 |
1989年 | 43篇 |
1988年 | 33篇 |
1987年 | 29篇 |
1986年 | 27篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 33篇 |
1982年 | 32篇 |
1981年 | 22篇 |
1980年 | 20篇 |
1979年 | 22篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1975年 | 6篇 |
1974年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
Jos María Robaina-Bordn Cristina Carranza-Rodríguez Michele Hernndez-Cabrera Margarita Bolaos-Rivero Elena Pisos-lamo Nieves Jan-Snchez Araceli Hernndez-Betancor Laura Surez-Hormiga Jos Luis Prez-Arellano 《Emerging infectious diseases》2021,27(2):570
To document the epidemiology, clinical features, and outcomes of murine typhus patients in the Canary Islands (Spain), we analyzed data that were retrospectively collected for 16 years for 221 patients. Murine typhus in the Canary Islands is characterized by a high rate of complications (31.6%), mainly liver, lung, kidney or central nervous system involvement. 相似文献
132.
Vural Alperen Carobbio Andrea Luigi Camillo Ferrari Marco Rampinelli Vittorio Schreiber Alberto Mattavelli Davide Doglietto Francesco Buffoli Barbara Rodella Luigi Fabrizio Taboni Stefano Tomasoni Michele Gualtieri Tommaso Deganello Alberto Hirtler Lena Nicolai Piero 《Neurosurgical review》2021,44(5):2857-2878
Neurosurgical Review - Transorbital endoscopic approaches are increasing in popularity as they provide corridors to reach various areas of the ventral skull base through the orbit. They can be used... 相似文献
133.
Sergio Romagnoli Matteo Marullo Michele Corbella Enrico Zero Andrea Parente Marco Bargagliotti 《The Journal of arthroplasty》2021,36(3):1080-1086
BackgroundRevision of a failed total hip arthroplasty (THA) poses technical challenges. The use of primary stems for revision can be advantageous for maintaining bone stock and reducing complications: small case series have reported promising results in the short-term to mid-term follow-up. The aim of this study was to evaluate the long-term clinical and functional results and survivorship of a consecutive series of THA femoral component revisions using a conical primary cementless stem (PCS).MethodsNinety-four stem revisions with a preoperative Paprosky I or II defect were analyzed at an average follow-up of 12.7 ± 5.4 years. Aseptic loosening was the reason for revision in 92.5% of cases. Twenty patients were lost to follow-up. Two subgroups were created: Group 1 (n = 59) underwent isolated stem revision; Group 2 (n = 15) underwent complete THA revision. All were evaluated preoperatively and postoperatively based on the Harris Hip Score (HHS), the Western Ontario and McMaster Universities Index (WOMAC) score, and the visual analog scale for pain (VAS). Residual trochanteric pain and length discrepancies were recorded. Radiographic evaluation included signs of osteolysis, subsidence, loosening, and heterotopic ossification.ResultsPCS survivorship was 100% at 5 years and 95.9% at 10 years. Overall, significant postoperative improvements (P < .01) were observed on the HHS (44.3 vs 86.9), WOMAC (42.8 vs 82.8), and VAS (7.0 vs 3.0). Postoperative scores on all scales were higher for Group 1 (P < .01). Three patients (4.1%) underwent further stem revision. Demarcation lines (1 mm) were found in 12 (16.2%) patients and significant heterotopic ossifications in 22 (29.7%).ConclusionThe use of PCS for stem revision in failed THA with a limited femoral bone defect is a reliable option for both isolated stem revision and concomitant cup revision in well-selected patients. 相似文献
134.
Guido Grappiolo Carmine F. Bruno Mattia Loppini Michele Mercurio Davide Castioni Giorgio Gasparini Olimpio Galasso 《The Journal of arthroplasty》2021,36(3):1060-1066
BackgroundDespite promising results at the mid-term followup, several aspects of conversion of the fused hip to total hip arthroplasty (THA) remain controversial. The aim of this study was to evaluate clinical and radiological outcomes with a minimum 5-year followup in patients who underwent conversion of the fused hip to THA.MethodsFifty-seven patients (59 hips) were evaluated. The Harris Hip Score (HHS), range of motion (ROM), and the Visual Analogue Scale (VAS) were used to assess hip function and low back pain. Subjective satisfaction with surgery and the presence of the Trendelenburg sign was also evaluated. Radiological assessment was performed pre- and postoperatively to evaluate loosening and heterotopic ossification (HO).ResultsAfter a mean followup of 13.0 ± 6.2 years, HHS and VAS significantly improved from 46.0 ± 16.7 to 80.8 ± 18.8 and from 4.4 ± 1.5 to 2.1 ± 1.4 (both P < .001), respectively. Twenty-three patients (40.4%) had a positive Trendelenburg sign, and HOs were found in 29 cases (49.1%). An overall 29.8% complication rate was noted. Smoking habits and rheumatoid arthritis were predictive of Trendelenburg sign (P = .046 and P = .038, respectively). Implant survival rate as the end point was 98.7 ± 1.3% at 5 years, 92.4 ± 3.3% at 10 years, 82.1 ± 5.7% at 15 years, and 73.4 ± 8.0% at 20 and 25 years. A worse cumulative implant survival rate was noted in patients who underwent previous hip surgery, defined as any hip operation before fusion (P = .005).ConclusionConversion of the fused hip to hip arthroplasty provides high levels of hip functionality and satisfaction with surgery at long-term followup. An implant survival rate higher than 70% can be expected 25 years postoperatively. 相似文献
135.
Antonio M. Calafiore Antonio Totaro Nicola Testa Cosimo Sacra Gaetano Castellano Stefano Guarracini Massimo Di Marco Sotirios Prapas Mario Gaudino Roberto Lorusso Domenico Paparella Michele Di Mauro 《Journal of cardiac surgery》2021,36(1):247-259
In secondary mitral regurgitation, the concept that the mitral valve (MV) is an innocent bystander, has been challenged by many studies in the last decades. The MV is a living structure with intrinsic plasticity that reacts to changes in stretch or in mechanical stress activating biohumoral mechanisms that have, as purpose, the adaptation of the valve to the new environment. If the adaptation is balanced, the leaflets increase both surface and length and the chordae tendineae lengthen: the result is a valve with different characteristics, but able to avoid or to limit the regurgitation. However, if the adaptation is unbalanced, the leaflets and the chords do not change their size, but become stiffer and rigid, with moderate or severe regurgitation. These changes are mediated mainly by a cytokine, the transforming growth factor‐β (TGF‐β), which is able to promote the changes that the MV needs to adapt to a new hemodynamic environment. In general, mild TGF‐β activation facilitates leaflet growth, excessive TGF‐β activation, as after myocardial infarction, results in profibrotic changes in the leaflets, with increased thickness and stiffness. The MV is then a plastic organism, that reacts to the external stimuli, trying to maintain its physiologic integrity. This review has the goal to unveil the secret life of the MV, to understand which stimuli can trigger its plasticity, and to explain why the equation “large heart = moderate/severe mitral regurgitation” and “small heart = no/mild mitral regurgitation” does not work into the clinical practice. 相似文献
136.
Michele Torre Vittorio Guerriero Luca Ramenghi Francesca Rizzo Annalisa Gallizia Oliviero Sacco 《Journal of pediatric surgery》2021,56(4):700-705
Background/PurposeMany studies on ex-preterm babies were conducted to evaluate their respiratory sequelae, but, to our knowledge, the condition described in this paper was never reported before and is not included in the classifications of thoracic anomalies proposed so far.MethodsClinical data and images of a novel thoracic deformity observed in the last 10 years are shown. This anomaly is characterized by an indentation of the ribs on both (less frequently one) anterolateral parts of the chest wall. All our patients with this condition were ex-preterm babies. We named this novel thoracic anomaly as “postprematurity thoracic dysplasia” (PPTD). Possible etiopathogenetic mechanisms and treatment options are discussed.ResultsWe observed 8 patients with variable range of respiratory symptoms. In 2 cases the malformation caused a severe functional restriction of lung volumes and surgery was performed to improve respiratory symptoms; in other cases the symptoms were mild or absent and the malformation was a matter of concern only for cosmesis.ConclusionsPPTD is a novel thoracic anomaly typical of ex-preterms. Clinical relevance is variable. In severe cases surgery can be considered.Level of evidenceIV. 相似文献
137.
Gaurang Nandkishor Vaidya Lawrence S.C. Czer Daniel Luthringer Michelle Kittleson Jignesh Patel David H. Chang Evan Kransdorf Dael Geft Babak Azarbal Michele Hamilton Jon Kobashigawa 《Transplantation proceedings》2021,53(1):348-352
BackgroundGiant cell myocarditis (GCM) has a poor prognosis without heart transplant, but post-transplant survival is unknown.PurposeTo describe the post-transplant survival of patients with GCM at a large transplant center.MethodsSeven patients underwent heart transplant for histologically confirmed GCM of the explanted heart. The median age was 59 years, and 43% (3 of 7) were female. All patients had cardiogenic shock, multiorgan failure, elevated troponin, and recurrent ventricular tachycardia, and some required mechanical circulatory support. All patients received rabbit antithymocyte globulin (rATG) in the perioperative period at a dose of 1.5 mg/kg daily for 1 to 5 days and 4 received intravenous immunoglobulin 1 g/kg daily for 2 days after rATG. All patients had early initiation of tacrolimus by first to third postoperative day depending on renal function, early mycophenolate, and high dose steroid. All were maintained using tacrolimus, mycophenolate, and prednisone.ResultsOne patient had asymptomatic recurrence of GCM at 3 months, managed by up-titration of tacrolimus, and had asymptomatic 2R cellular rejection at 4 months, managed with steroid bolus. No patient had high-grade rejection. One patient died at 267 days, possibly of GCM. Six of 7 (86%) remain alive at a median of 842 days (2.3 years) post transplant.ConclusionsPatients with GCM have excellent post-transplant survival with use of rATG and triple drug immunosuppressive therapy; however, some patients remain at risk for GCM recurrence after transplant, which may respond to augmented immunosuppression. 相似文献
138.
139.
La Mendola Roberta Bencivenga Maria Torroni Lorena Alberti Luca Sacco Michele Casella Francesco Ridolfi Cecilia Simoni Nicola Micera Renato Pavarana Michele Verlato Giuseppe Giacopuzzi Simone 《Annals of surgical oncology》2021,28(6):3034-3043
Annals of Surgical Oncology - Although pathological complete response (pCR) after multimodal treatment for esophageal cancer is associated to the best prognosis, recurrence may occur in... 相似文献
140.
La Mendola Roberta Bencivenga Maria Torroni Lorena Sacco Michele Giacopuzzi Simone 《Annals of surgical oncology》2021,28(6):3044-3045
Annals of Surgical Oncology - 相似文献